Instil Bio, Inc.
TIL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $12 | $0 | $0 | $741 |
| Gross Profit | -$12 | $0 | $0 | -$741 |
| % Margin | – | – | – | – |
| R&D Expenses | $9,127 | $6,743 | $5,371 | $1,099 |
| G&A Expenses | $5,895 | $6,157 | $9,109 | $0 |
| SG&A Expenses | $5,895 | $6,157 | $9,109 | $9,632 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $10,540 | $16,082 | $0 |
| Operating Expenses | $15,010 | $23,440 | $30,562 | $10,731 |
| Operating Income | -$15,022 | -$23,440 | -$30,562 | -$11,472 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,435 | $2,046 | $2,362 | -$423 |
| Pre-Tax Income | -$13,587 | -$21,394 | -$28,200 | -$11,895 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13,587 | -$21,394 | -$28,200 | -$11,895 |
| % Margin | – | – | – | – |
| EPS | -2.01 | -3.24 | -4.32 | -1.82 |
| % Growth | 38% | 25% | -137.4% | – |
| EPS Diluted | -2.01 | -3.24 | -4.32 | -1.82 |
| Weighted Avg Shares Out | 6,758 | 6,597 | 6,533 | 6,526 |
| Weighted Avg Shares Out Dil | 6,758 | 6,597 | 6,533 | 6,526 |
| Supplemental Information | – | – | – | – |
| Interest Income | $893 | $1,044 | $1,175 | $1,352 |
| Interest Expense | $1,582 | $1,582 | $1,098 | $2,590 |
| Depreciation & Amortization | $255 | $12 | $498 | $741 |
| EBITDA | -$11,750 | -$19,800 | -$26,816 | -$8,564 |
| % Margin | – | – | – | – |